232 related articles for article (PubMed ID: 34083513)
1. Pre-emptive pharmacological inhibition of fatty acid-binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism.
Chen Y; Dai Y; Song K; Huang Y; Zhang L; Zhang C; Yan Q; Gao H
Cell Death Dis; 2021 Jun; 12(6):572. PubMed ID: 34083513
[TBL] [Abstract][Full Text] [Related]
2. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
Chen Y; Yan Q; Lv M; Song K; Dai Y; Huang Y; Zhang L; Zhang C; Gao H
Cell Death Dis; 2020 Nov; 11(11):994. PubMed ID: 33219209
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Fatty Acid-Binding Protein 4 Attenuated Kidney Fibrosis by Mediating Macrophage-to-Myofibroblast Transition.
Feng Y; Guo F; Xia Z; Liu J; Mai H; Liang Y; Zhu G; Li Y; Bai L; Li L; Huang R; Shi M; Ma L; Fu P
Front Immunol; 2020; 11():566535. PubMed ID: 33101287
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor γ-mediated ferroptosis.
Fan X; Xu M; Ren Q; Fan Y; Liu B; Chen J; Wang Z; Sun X
Bioengineered; 2022 Apr; 13(4):10540-10551. PubMed ID: 35441580
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
[TBL] [Abstract][Full Text] [Related]
7. Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation.
Sun J; Chen X; Liu T; Jiang X; Wu Y; Yang S; Hua W; Li Z; Huang H; Ruan X; Du X
Med Sci Monit; 2018 Mar; 24():1484-1492. PubMed ID: 29528039
[TBL] [Abstract][Full Text] [Related]
8. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
9. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis.
Miguel V; Tituaña J; Herrero JI; Herrero L; Serra D; Cuevas P; Barbas C; Puyol DR; Márquez-Expósito L; Ruiz-Ortega M; Castillo C; Sheng X; Susztak K; Ruiz-Canela M; Salas-Salvadó J; González MAM; Ortega S; Ramos R; Lamas S
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33465052
[TBL] [Abstract][Full Text] [Related]
10. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
[TBL] [Abstract][Full Text] [Related]
12. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
[TBL] [Abstract][Full Text] [Related]
13. FABP4 inhibitor BMS309403 protects against hypoxia-induced H9c2 cardiomyocyte apoptosis through attenuating endoplasmic reticulum stress.
Sun F; Du J; Li H; Hao S; Zhao G; Lu F
J Cell Mol Med; 2020 Oct; 24(19):11188-11197. PubMed ID: 32896039
[TBL] [Abstract][Full Text] [Related]
14. FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism.
Qiao Y; Liu L; Yin L; Xu L; Tang Z; Qi Y; Mao Z; Zhao Y; Ma X; Peng J
Cell Death Dis; 2019 May; 10(6):382. PubMed ID: 31097687
[TBL] [Abstract][Full Text] [Related]
15. MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity.
Zhou S; Ling X; Zhu J; Liang Y; Feng Q; Xie C; Li J; Chen Q; Chen S; Miao J; Zhang M; Li Z; Shen W; Li X; Wu Q; Wang X; Liu R; Wang C; Hou FF; Kong Y; Liu Y; Zhou L
Theranostics; 2024; 14(4):1583-1601. PubMed ID: 38389852
[No Abstract] [Full Text] [Related]
16. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
17. Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis.
Liu L; Ning X; Wei L; Zhou Y; Zhao L; Ma F; Bai M; Yang X; Wang D; Sun S
Theranostics; 2022; 12(8):3758-3775. PubMed ID: 35664054
[No Abstract] [Full Text] [Related]
18. MiR-9-5p protects from kidney fibrosis by metabolic reprogramming.
Fierro-Fernández M; Miguel V; Márquez-Expósito L; Nuevo-Tapioles C; Herrero JI; Blanco-Ruiz E; Tituaña J; Castillo C; Cannata P; Monsalve M; Ruiz-Ortega M; Ramos R; Lamas S
FASEB J; 2020 Jan; 34(1):410-431. PubMed ID: 31914684
[TBL] [Abstract][Full Text] [Related]
19. Autophagy activation contributes to lipid accumulation in tubular epithelial cells during kidney fibrosis.
Yan Q; Song Y; Zhang L; Chen Z; Yang C; Liu S; Yuan X; Gao H; Ding G; Wang H
Cell Death Discov; 2018; 4():2. PubMed ID: 30062051
[TBL] [Abstract][Full Text] [Related]
20. ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis.
Jao TM; Nangaku M; Wu CH; Sugahara M; Saito H; Maekawa H; Ishimoto Y; Aoe M; Inoue T; Tanaka T; Staels B; Mori K; Inagi R
Kidney Int; 2019 Mar; 95(3):577-589. PubMed ID: 30639234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
